AGENUS INC Stock Agreements
15 Contracts & Agreements
- Stock Purchase Agreement, dated as of June 20, 2020, by and among Agenus Inc., Betta Investment (Hong Kong) Limited, and Betta Pharmaceuticals Co., Ltd (Filed With SEC on August 10, 2020)
- Stock Purchase Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)
- Stock Purchase Agreement, dated October 10, 2018, between the Company and the purchasers listed on Exhibit A thereto (Filed With SEC on October 11, 2018)
- stock PURCHASE AGREEMENT (Filed With SEC on May 4, 2017)
- AGENUS INC. NON-QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENT (Filed With SEC on August 3, 2015)
- AGENUS INC. RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on June 30, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)
- AGENUS INC. Common Stock (par value 0.01) AT MARKET ISSUANCE SALES AGREEMENT (Filed With SEC on March 2, 2012)
- ANTIGENICS INC. 20,000,000 Shares Of Common Stock At Market Issuance Sales Agreement (Filed With SEC on March 1, 2010)
- ANTIGENICS INC. RESTRICTED STOCK AWARDAGREEMENT (Filed With SEC on June 15, 2009)
- ANTIGENICS INC. 9,500,000 Shares Of Common Stock (Filed With SEC on July 10, 2008)
- ANTIGENICS INC. 9,500,000 Shares Of Common Stock (Filed With SEC on March 14, 2008)
- ANTIGENICS INC. 1999 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED (Filed With SEC on June 11, 2007)
- EX-10.1 Form of Non-Statutory Stock Option Certificate (Filed With SEC on December 15, 2004)
- 5,000,000 Shares Common Stock ($0.01 Par Value) (Filed With SEC on February 4, 2004)
